Impact of <i>SPOP</i> Mutations on Clinical Outcomes in Metastatic Prostate Cancer

<i>SPOP</i> mutations were associated with longer OS despite the presence of aggressive clinical features. The distinct clinical and molecular features of <i>SPOP</i>-mutated PC support its consideration as a unique molecular subtype with prognostic implications.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2025-12-01
DOI
https://doi.org/10.1200/po-25-00590
Citations
1
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer

Alexandra Sokolova, Michael Thomas Schweizer, Jones T. Nauseef, Laura Graham et al.
1 citations
JCO Precision Oncology
Prostate Cancer Treatment and Research
1.52
article

Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer

Alexandra Sokolova, Michael Thomas Schweizer, Jones T. Nauseef, Laura Graham, Amanda Pilling, Vadim S. Koshkin, Andrew J. Armstrong, Clara Hwang, Mehmet Asım Bilen, Yousef Zakharia, Rohan Garje, Pedro Coelho Barata, Deepak Kilari, Rana R. McKay, Shabi Haider, Frank C. Cackowski, Ruben Raychaudhuri, Shoshana Rothstein, Adanma Ayanambakkam, Abhishek Tripathi, Erica Chin, Tanya Barauskas Dorff, Zachery R. Reichert, Joseph J. Park, Yao Ye, Nicholas Henderson, Kyra Yamamoto
article en
1 citations

Abstract

<i>SPOP</i> mutations were associated with longer OS despite the presence of aggressive clinical features. The distinct clinical and molecular features of <i>SPOP</i>-mutated PC support its consideration as a unique molecular subtype with prognostic implications.

JCO Precision OncologyVol. 9(9)
Baptist Hospital of Miami (US), Emory University (US), Oregon Health & Science University (US), University of California, San Francisco (US), Wayne State University (US), University of Washington (US), Medical College of Wisconsin (US), Cornell University (US), University of Michigan (US), Henry Ford Hospital (US), University of California San Diego (US), Fred Hutch Cancer Center (US), The Barbara Ann Karmanos Cancer Institute (US), Baptist Health South Florida (US), City of Hope (US), University Hospitals Seidman Cancer Center (US), Duke Medical Center (US), Mayo Clinic Hospital (US), UCSF Helen Diller Family Comprehensive Cancer Center (US), Weill Cornell Medicine (US), University of Oklahoma Health Sciences Center (US), University of Colorado Anschutz Medical Campus (US), University of Colorado Denver (US)
Openalex Percentile: Top 12%
Prostate Cancer Treatment and Research
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.